Blue Granite Capital’s Allergan plc AGN Stock Holding History

Blue Granite Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,839	Closed	-$377K	–	141
2017 Q3	$377K	Buy	+1,839	New	+$428K	0.26%	87

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Blue Granite Capital's AGN Position: Q4 2017 in Review

Blue Granite Capital sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,839 shares — an estimated $377K sold.

Blue Granite Capital first reported a position in AGN in Q3 2017 and held it in 1 quarter. The position peaked at $377K in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

Blue Granite Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
Blue Granite Capital sold 1,839 Allergan plc shares in Q4 2017, an estimated $377K.
Blue Granite Capital first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
Blue Granite Capital's Allergan plc position peaked at $377K in Q3 2017.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.